Trace Amine-Associated Receptor 1 (TAAR1): Molecular and Clinical Insights for the Treatment of Schizophrenia and Related Comorbidities.
Journal
ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411
Informations de publication
Date de publication:
11 Mar 2022
11 Mar 2022
Historique:
received:
31
01
2022
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Schizophrenia is a complex and severe mental illness. Current treatments for schizophrenia typically modulate dopaminergic neurotransmission by D
Identifiants
pubmed: 35311018
doi: 10.1021/acsptsci.2c00016
pmc: PMC8922295
doi:
Types de publication
Journal Article
Langues
eng
Pagination
183-188Informations de copyright
© 2022 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
N Engl J Med. 2020 Apr 16;382(16):1497-1506
pubmed: 32294346
Mol Pharmacol. 2001 Dec;60(6):1181-8
pubmed: 11723224
ACS Chem Biol. 2009 Mar 20;4(3):209-20
pubmed: 19256523
Schizophr Res. 2018 Apr;194:78-85
pubmed: 28416205
Neuropsychopharmacology. 2017 Mar;42(4):941-950
pubmed: 27857125
Am J Psychiatry. 2012 Nov;169(11):1203-10
pubmed: 23034655
Br J Psychiatry. 2016 Nov;209(5):361-365
pubmed: 27802977
Pharmacol Rev. 2018 Jul;70(3):549-620
pubmed: 29941461
Chem Biol Drug Des. 2013 Apr;81(4):509-16
pubmed: 22883051
Mol Psychiatry. 2020 Sep;25(9):1910-1919
pubmed: 32203158
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
Mol Psychiatry. 2021 Aug 10;:
pubmed: 34376825
Pharmacol Ther. 2017 Dec;180:161-180
pubmed: 28723415
N Engl J Med. 2020 Apr 16;382(16):1555-1556
pubmed: 32294351
Eur Neuropsychopharmacol. 2015 Nov;25(11):2049-61
pubmed: 26372541
Neuropsychopharmacology. 2015 Aug;40(9):2217-27
pubmed: 25749299
J Pharmacol Exp Ther. 2019 Oct;371(1):1-14
pubmed: 31371483
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71
pubmed: 11459929
Mol Pharmacol. 2011 Sep;80(3):416-25
pubmed: 21670104